Bellicum Pharmaceuticals (BLCM) Priced

Early-stage biotech developing controllable cancer immunotherapies.

Health Care - Biotechnology

IPO Performance
Latest Trade $13.62 0.00 (0.0%)
First Day Return 25.7%
Return from IPO -28.3%
 
Bellicum Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 11/18/2014
Offer Price $19.00
Price Range $15.00 - $17.00
Offer Shares (mm) 7.4
Deal Size ($mm) 140
 
IPO Data
IPO Date 12/17/2014
Offer Price $19.00
Price Range $15.00 - $17.00
Offer Shares (mm) 7.4
Deal Size ($mm) $140
 
Underwriters
more
Business Overview
Early-stage biotech developing controllable cancer immunotherapies.
Early-stage biotech developing controllable cancer immunotherapies.
more
Company Data
Headquarters Houston, TX
Founded 2004
Employees 30
Website www.bellicum.com
 

Performance vs. IPO Index (IPOUSA)